Surveillance of primary sclerosing cholangitis – a comparison of scheduled or on-demand ERCP with annual MRI surveillance: a multicenter study
Endoscopy · 01.05.2025 · 57 (05) · 431-440
DOI: 10.1055/a-2511-3422 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Endoscopy, erschienen am 01.05.2025. Verfasst von Nina Barner-Rasmussen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, HUS Abdominal Center, Helsinki University Central Hospital, Helsinki, Finland. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Cholangiocarcinoma, Cholangiopancreatography, Endoscopic Retrograde, Cholangiopancreatography, Magnetic Resonance. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: State Funding for University-level Health Research, Finnish Cancer Foundation.
Abstract (Originalsprache)
Primary sclerosing cholangitis (PSC) is associated with a high risk of hepatobiliary malignancy, especially cholangiocarcinoma (CCA). There are no good tumor markers to screen for CCA, and current recommendations for PSC monitoring are mainly based on expert opinions. The optimal strategy to assess disease progression and screen for CCA – the main cause of death of PSC patients – remains unclear. We aimed to compare three different surveillance strategies and their effect on patient outcomes. Data from three distinct PSC cohorts with different surveillance strategies – scheduled endoscopic retrograde cholangiopancreatography (ERCP), annual magnetic resonance imaging/cholangiopancreatography (MRI/MRCP) surveillance, and on-demand ERCP according to ESGE/EASL guidelines – was collected. Patients with PSC diagnosed in 1990 or later were included and the last day of follow-up was 31 December 2023. The composite end point consisted of hepatobiliary malignancy, liver transplantation, or liver-related death. 1629 PSC patients were included, with a median follow-up of 8–11 years. The cumulative incidence of the composite end point was lowest in the group undergoing scheduled ERCP (14.1%, 95%CI 12.0%–16.4%) and highest in the on-demand ERCP cohort (35.0%, 95%CI 28.4%–42.0%). Although the cumulative incidence of CCA was lower in the scheduled ERCP group than in the other groups, it did not differ statistically significantly from the MRI/MRCP surveillance group. No differences were seen in liver-related deaths between the surveillance strategies. In this study comparing scheduled ERCP, annual MRI/MRCP surveillance, and on-demand ERCP, the strategy based on scheduled ERCP using individual risk stratification is associated with better overall prognosis and outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology, HUS Abdominal Center, Helsinki University Central Hospital, Helsinki, Finland.
- Department of Molecular and Clinical Medicine, Wallenberg Laboratory, University of Gothenburg, Gothenburg, Sweden.
- Department of Gastroenterology and Hepatology, Amsterdam UMC Locatie AMC, Amsterdam, Netherlands.
- Department of Gastroenterology and Hepatology, Karolinska University Hospital, Stockholm, Sweden.
- Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
- Primary Health Care, Folkhalsan Research Centre, Helsinki, Finland.
Förderung
- State Funding for University-level Health Research
- Finnish Cancer Foundation
Zitieren
APA
Barner-Rasmussen, N., Molinaro, A., Mol, B., Ponsioen, C., Bergquist, A., Kautiainen, H., & Färkkilä, M. A. (2025). Surveillance of primary sclerosing cholangitis – a comparison of scheduled or on-demand ERCP with annual MRI surveillance: a multicenter study. Endoscopy, 57(05), 431-440. https://doi.org/10.1055/a-2511-3422
Vancouver
Barner-Rasmussen N, Molinaro A, Mol B, Ponsioen C, Bergquist A, Kautiainen H, et al. Surveillance of primary sclerosing cholangitis – a comparison of scheduled or on-demand ERCP with annual MRI surveillance: a multicenter study. Endoscopy. 2025;57(05):431-440. doi:10.1055/a-2511-3422
BibTeX
@article{BarnerRasmussen2025,
author = {Barner-Rasmussen, Nina and Molinaro, Antonio and Mol, Bregje and Ponsioen, Cyriel and Bergquist, Annika and Kautiainen, Hannu and Färkkilä, Martti A},
title = {Surveillance of primary sclerosing cholangitis – a comparison of scheduled or on-demand ERCP with annual MRI surveillance: a multicenter study},
journal = {Endoscopy},
year = {2025},
volume = {57},
number = {05},
pages = {431--440},
doi = {10.1055/a-2511-3422}
}
EUVIMED